Oruka Therapeutics (ORKA) Other Working Capital Changes (2010 - 2026)
Oruka Therapeutics' quarterly Other Working Capital Changes came in at -$461000.0 in Q1 2026, down 411.49% year-on-year from $148000.0 in Q1 2025, and down 157.27% quarter-over-quarter from $805000.0 in Q4 2025.
Oruka Therapeutics has reported Other Working Capital Changes for 17 years, with the latest figure at -$461000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 411.49% year-over-year to -$461000.0; the trailing twelve-month figure through Mar 2026 stood at $3.4 million (up 812.5% YoY), and the FY2025 full-year result was $4.0 million, up 28471.43% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$461000.0, down from $805000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $2.4 million in Q3 2025, with the low at -$2.0 million in Q4 2024.
- Average Other Working Capital Changes over 5 years is $152705.9, with a median of -$200000.0 recorded in 2023.
- Peak annual rise in Other Working Capital Changes reached 1088.0% in 2024, while the deepest fall reached 737.82% in 2024.
- Tracing ORKA's Other Working Capital Changes over 5 years: stood at -$357000.0 in 2022, then soared by 33.33% to -$238000.0 in 2023, then tumbled by 737.82% to -$2.0 million in 2024, then soared by 140.37% to $805000.0 in 2025, then sank by 157.27% to -$461000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$461000.0 (Q1 2026), $805000.0 (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -461,000.00 |
| Mar 31, 2026 | -461,000.00 |
| Dec 31, 2025 | 805,000.00 |
| Dec 31, 2025 | 805,000.00 |
| Sep 30, 2025 | 2.40 Mn |
| Sep 30, 2025 | 2.40 Mn |
| Jun 30, 2025 | 617,000.00 |
| Jun 30, 2025 | 617,000.00 |
| Mar 31, 2025 | 148,000.00 |
| Mar 31, 2025 | 148,000.00 |
| Dec 31, 2024 | -1.99 Mn |
| Dec 31, 2024 | -1.99 Mn |
| Sep 30, 2024 | 1.98 Mn |
| Sep 30, 2024 | 1.98 Mn |
| Jun 30, 2024 | -602,000.00 |
| Jun 30, 2024 | -602,000.00 |
| Mar 31, 2024 | 606,000.00 |
| Mar 31, 2024 | 606,000.00 |
| Dec 31, 2023 | -238,000.00 |
| Dec 31, 2023 | -238,000.00 |
| Sep 30, 2023 | -200,000.00 |
| Sep 30, 2023 | -200,000.00 |
| Jun 30, 2023 | -253,000.00 |
| Jun 30, 2023 | -253,000.00 |
| Mar 31, 2023 | 598,000.00 |
| Mar 31, 2023 | 598,000.00 |
| Dec 31, 2022 | -357,000.00 |
| Dec 31, 2022 | -357,000.00 |
| Sep 30, 2022 | -607,000.00 |
| Sep 30, 2022 | -607,000.00 |
| Jun 30, 2022 | -258,000.00 |
| Jun 30, 2022 | -258,000.00 |
| Mar 31, 2022 | 414,000.00 |
| Mar 31, 2022 | 414,000.00 |
| Dec 31, 2021 | -283,000.00 |
| Dec 31, 2021 | -283,000.00 |
| Sep 30, 2021 | -258,000.00 |
| Sep 30, 2021 | -258,000.00 |
| Jun 30, 2021 | -143,000.00 |
| Jun 30, 2021 | -143,000.00 |
| Mar 31, 2021 | 840,000.00 |
| Mar 31, 2021 | 840,000.00 |
| Dec 31, 2020 | 67,000.00 |
| Dec 31, 2020 | 67,000.00 |
| Sep 30, 2020 | 376,000.00 |
| Sep 30, 2020 | 376,000.00 |
| Jun 30, 2020 | -170,000.00 |
| Jun 30, 2020 | -170,000.00 |
| Mar 31, 2020 | 75,000.00 |
| Mar 31, 2020 | 75,000.00 |
| Dec 31, 2019 | -142,000.00 |
| Dec 31, 2019 | -142,000.00 |
| Sep 30, 2019 | -98,000.00 |
| Sep 30, 2019 | -98,000.00 |
| Jun 30, 2019 | -156,000.00 |
| Jun 30, 2019 | -156,000.00 |
| Mar 31, 2019 | -5,000.00 |
| Mar 31, 2019 | -5,000.00 |
| Dec 31, 2018 | -167,000.00 |
| Dec 31, 2018 | -167,000.00 |
| Sep 30, 2018 | -39,000.00 |
| Sep 30, 2018 | -39,000.00 |
| Jun 30, 2018 | -196,000.00 |
| Jun 30, 2018 | -196,000.00 |
| Mar 31, 2018 | -287,000.00 |
| Mar 31, 2018 | -287,000.00 |
| Dec 31, 2017 | -251,000.00 |
| Dec 31, 2017 | -251,000.00 |
| Sep 30, 2017 | -84,000.00 |
| Sep 30, 2017 | -84,000.00 |
| Jun 30, 2017 | -176,000.00 |
| Jun 30, 2017 | -176,000.00 |
| Mar 31, 2017 | 74,000.00 |
| Mar 31, 2017 | 74,000.00 |
| Dec 31, 2016 | -51,000.00 |
| Dec 31, 2016 | -51,000.00 |
| Sep 30, 2016 | -165,000.00 |
| Sep 30, 2016 | -165,000.00 |
| Jun 30, 2016 | -14,000.00 |
| Jun 30, 2016 | -14,000.00 |
| Mar 31, 2016 | 277,000.00 |
| Mar 31, 2016 | 277,000.00 |
| Dec 31, 2015 | -210,000.00 |
| Dec 31, 2015 | -210,000.00 |
| Sep 30, 2015 | -1,000.00 |
| Sep 30, 2015 | -1,000.00 |
| Jun 30, 2015 | -141,000.00 |
| Jun 30, 2015 | -141,000.00 |
| Mar 31, 2015 | 139,000.00 |
| Mar 31, 2015 | 139,000.00 |
| Sep 30, 2014 | -699,000.00 |
| Sep 30, 2014 | -699,000.00 |
| Jun 30, 2014 | 3,000.00 |
| Jun 30, 2014 | 3,000.00 |
| Mar 31, 2014 | 698,000.00 |
| Mar 31, 2014 | 698,000.00 |
| Dec 31, 2013 | 30,000.00 |
| Dec 31, 2013 | 30,000.00 |
| Sep 30, 2013 | -29,000.00 |
| Sep 30, 2013 | -29,000.00 |
| Jun 30, 2013 | 5,000.00 |
| Jun 30, 2013 | 5,000.00 |
| Mar 31, 2013 | -20,000.00 |
| Mar 31, 2013 | -20,000.00 |
| Dec 31, 2012 | -218,000.00 |
| Dec 31, 2012 | -218,000.00 |
| Sep 30, 2012 | -65,000.00 |
| Sep 30, 2012 | -65,000.00 |
| Jun 30, 2012 | 25,000.00 |
| Jun 30, 2012 | 25,000.00 |
| Mar 31, 2012 | -20,000.00 |
| Mar 31, 2012 | -20,000.00 |
| Dec 31, 2011 | 46,000.00 |
| Dec 31, 2011 | 46,000.00 |
| Sep 30, 2011 | -20,000.00 |
| Sep 30, 2011 | -20,000.00 |
| Jun 30, 2011 | -129,000.00 |
| Jun 30, 2011 | -129,000.00 |
| Mar 31, 2011 | 89,000.00 |
| Mar 31, 2011 | 89,000.00 |
| Dec 31, 2010 | -74,000.00 |
| Dec 31, 2010 | -74,000.00 |
| Sep 30, 2010 | -22,000.00 |
| Sep 30, 2010 | -22,000.00 |